open access

Vol 65, No 1 (2014)
Original papers
Published online: 2014-02-19
Submitted: 2014-02-19
Accepted: 2014-02-19
Get Citation

Functional polymorphisms of the leptin and leptin receptor genes are associated with longevity and with the risk of myocardial infarction and of type 2 diabetes mellitus

Małgorzata Roszkowska-Gancarz, Alina Kurylowicz, Jacek Polosak, Małgorzata Mossakowska, Edward Franek, Monika Puzianowska-Kuźnicka
DOI: 10.5603/EP.2014.0002
·
Endokrynologia Polska 2014;65(1):11-16.

open access

Vol 65, No 1 (2014)
Original papers
Published online: 2014-02-19
Submitted: 2014-02-19
Accepted: 2014-02-19

Abstract

Introduction: Longevity is commonly associated with good health and with delayed onset of age-related diseases with usually benign course. Leptin (LEP) significantly affects metabolism and numerous functions of the organism. To find out if extreme longevity and its phenotype are associated with genetic variants of leptin and leptin receptor (LEPR) genes, we analysed the frequencies of the –2548 G/A and +19 G/A LEP, as well as the K109R, Q223R, and K656N LEPR polymorphisms in centenarians and in control groups.

Material and methods: The frequencies of the LEP and LEPR polymorphisms were tested by restriction fragment length polymorphism in 128 centenarians, 414 young controls (Y), 226 myocardial infarction (MI) patients, and 190 type 2 diabetes mellitus (DM2) patients.

Results: The GG genotype of the –2548 G/A LEP polymorphism was significantly more common in centenarians than in the Y, MI and DM2 groups (p = 0.048, p = 0.003, p = 0.049, respectively). In addition, the AA genotype of the K109R LEPR polymorphism was significantly less frequent in centenarians than in the Y, MI, and DM2 groups (p = 0.026, p = 0.013, and p = 0.001, respectively).

Conclusions: We suggest that the leptin pathway plays a role in the regulation of longevity, possibly by modulating the risk of development of MI and of DM2. (Endokrynol Pol 2014; 65 (1): 11–16)

Abstract

Introduction: Longevity is commonly associated with good health and with delayed onset of age-related diseases with usually benign course. Leptin (LEP) significantly affects metabolism and numerous functions of the organism. To find out if extreme longevity and its phenotype are associated with genetic variants of leptin and leptin receptor (LEPR) genes, we analysed the frequencies of the –2548 G/A and +19 G/A LEP, as well as the K109R, Q223R, and K656N LEPR polymorphisms in centenarians and in control groups.

Material and methods: The frequencies of the LEP and LEPR polymorphisms were tested by restriction fragment length polymorphism in 128 centenarians, 414 young controls (Y), 226 myocardial infarction (MI) patients, and 190 type 2 diabetes mellitus (DM2) patients.

Results: The GG genotype of the –2548 G/A LEP polymorphism was significantly more common in centenarians than in the Y, MI and DM2 groups (p = 0.048, p = 0.003, p = 0.049, respectively). In addition, the AA genotype of the K109R LEPR polymorphism was significantly less frequent in centenarians than in the Y, MI, and DM2 groups (p = 0.026, p = 0.013, and p = 0.001, respectively).

Conclusions: We suggest that the leptin pathway plays a role in the regulation of longevity, possibly by modulating the risk of development of MI and of DM2. (Endokrynol Pol 2014; 65 (1): 11–16)

Full Text:

View HTML
Get Citation

Keywords

leptin gene (LEP); leptin receptor gene (LEPR); polymorphism; longevity; centenarians; myocardial infarction (MI); type 2 diabetes mellitus (DM2)

About this article
Title

Functional polymorphisms of the leptin and leptin receptor genes are associated with longevity and with the risk of myocardial infarction and of type 2 diabetes mellitus

Journal

Endokrynologia Polska

Issue

Vol 65, No 1 (2014)

Pages

11-16

Published online

2014-02-19

DOI

10.5603/EP.2014.0002

Bibliographic record

Endokrynologia Polska 2014;65(1):11-16.

Keywords

leptin gene (LEP)
leptin receptor gene (LEPR)
polymorphism
longevity
centenarians
myocardial infarction (MI)
type 2 diabetes mellitus (DM2)

Authors

Małgorzata Roszkowska-Gancarz
Alina Kurylowicz
Jacek Polosak
Małgorzata Mossakowska
Edward Franek
Monika Puzianowska-Kuźnicka

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl